{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:59Z","timestamp":1761516779501,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.4158\/ep-2019-0111","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:11:24Z","timestamp":1559841084000},"page":"899-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intermittent Intensive Insulin Therapy for Type 2 Diabetes: Effects on Hypoglycemia, Weight Gain, and Quality of Life Over 2 Years"],"prefix":"10.1016","volume":"25","author":[{"given":"Alexandra","family":"Emery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haysook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline K.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Retnakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0111_bb0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2213-8587(13)70006-8","article-title":"Short-term intensive insulin therapy in type 2 diabetes: a systematic review and meta-analysis","volume":"1","author":"Kramer","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.4158\/EP-2019-0111_bb0015","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicenter randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.4158\/EP-2019-0111_bb0020","doi-asserted-by":"crossref","first-page":"E1398","DOI":"10.1152\/ajpendo.00447.2013","article-title":"Determinants of reversibility of beta-cell dysfunction in response to short-term intensive insulin therapy in early type 2 diabetes","volume":"305","author":"Kramer","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.4158\/EP-2019-0111_bb0025","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/dc10-2105","article-title":"Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and beta-cell function in subjects with long-term remission","volume":"34","author":"Hu","year":"2011","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0111_bb0030","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/dc08-0075","article-title":"Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0111_bb0035","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diacare.27.5.1028","article-title":"Short-term intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"27","author":"Ryan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0111_bb0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/diacare.20.9.1353","article-title":"Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment","volume":"20","author":"Ilkova","year":"1997","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0111_bb0045","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1210\/jc.2015-1947","article-title":"Effect of short-term intensive insulin therapy on post-challenge hyperglucagonemia in early type 2 diabetes","volume":"100","author":"Kramer","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0111_bb0050","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1210\/jc.2018-01468","article-title":"Predictors of long-term glycemic remission after 2-week intensive insulin treatment in newly diagnosed type 2 diabetes","volume":"104","author":"Wang","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0111_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000270","article-title":"Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes","volume":"4","author":"Kramer","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"suppl 5","key":"10.4158\/EP-2019-0111_bb0060","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.jcjd.2015.08.007","article-title":"Novel strategies for inducing glycemic remission during the honeymoon phase of type 2 diabetes","volume":"39","author":"Retnakaran","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.4158\/EP-2019-0111_bb0065","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/dom.13236","article-title":"Two-year trial of intermittent insulin therapy vs metformin for the preservation of beta-cell function after initial short-term intensive insulin induction in early type 2 diabetes","volume":"20","author":"Retnakaran","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP-2019-0111_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11892-005-0039-7","article-title":"Health-related quality of life among adults with diabetes","volume":"5","author":"Norris","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.4158\/EP-2019-0111_bb0075","first-page":"265","article-title":"Canadian normative data for the SF-36 health survey","volume":"163","author":"Hopman","year":"2000","journal-title":"CMAJ"},{"key":"10.4158\/EP-2019-0111_bb0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/bmj.312.7027.364","article-title":"Ways of measuring rates of recurrent events","volume":"312","author":"Glynn","year":"1996","journal-title":"BMJ"},{"key":"10.4158\/EP-2019-0111_bb0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events","volume":"62","author":"Lin","year":"2000","journal-title":"J R Stat Soc Ser B Stat Meth"},{"key":"10.4158\/EP-2019-0111_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.4158\/EP-2019-0111_bb0095","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/dc14-0396","article-title":"Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment","volume":"37","author":"Halban","year":"2014","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2019-0111_bb0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/dme.12671","article-title":"Clinical predictors and time course of the improvement in beta-cell function with short-term intensive insulin therapy in patients with type 2 diabetes","volume":"32","author":"Stein","year":"2015","journal-title":"Diabetic Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20351788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20351788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:03Z","timestamp":1761516423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20351788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1530891X20351788"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0111","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent Intensive Insulin Therapy for Type 2 Diabetes: Effects on Hypoglycemia, Weight Gain, and Quality of Life Over 2 Years","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}